Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Idea to Innovation

University of Toronto

$15,000.00

Streptococcus salivarius probiotics against dental caries pathogens - Market Assessment phase

EF 2021-22

Résumé
Our product is geared towards the prevention of dental cavities or caries in children and adults globally. Dental caries is the world's leading chronic childhood disease with a significant impact on patients, their families and health care system worldwide. Because of global population growth and increased tooth retention, the number of affected individuals is expected to grow substantially. We propose to use a "friendly" or probiotic bacterial strain to prevent dental caries. We identified one such bacterial strain, LAB813, from the mouth of a healthy cavity-free child and showed that it has potent anti-inhibitory activities against caries-causing bacteria. To guide us in the commercial development of the probiotic, a market assessment is now planned by a team comprising scientists, institutional (University of Toronto) Innovations and Partnerships Office, IPO, and a marketing assessment company (Adventus Research & Consulting, Inc.). Individuals tasked with performing the market assessment study are well-skilled and the relevant expertise and experience to conduct an assessment of the market in the specific markets of oral care, dental appliances and probiotics. Information such as market size, trends, opportunities/challenges/barriers to entry, adoption/commercialization of the technology, and product positioning will be gathered. Secondary market data will be reviewed prior to conducting a primary market research which will be in the form of in-depth interviews of a total of 20-22 key stakeholders. These stakeholders will comprise potential end-users/recommenders such as oral healthcare providers and companies interested in oral healthcare products, industry observers, regulatory agencies and venture capital firms. Interviews will be conducted posing questions related to satisfaction and solution, possible delivery modes, market acceptance, cost comparison, etc. Information gathered from all assessment will be compiled in a report that will be discussed and analyzed by the scientists and IPO. The market assessment report will be a crucial piece of the decision-making process in the development of the probiotic product for commercialization.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
561440-2021
Name nom
Gong, Siew-Ging
Department département
Dentistry, Faculty of
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2021
Award amount
15000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Life sciences research related to human health and disease
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Installment
inst:1
Partie
1
Nb partie
1
Application title
Streptococcus salivarius probiotics against dental caries pathogens - Market Assessment phase
Keyword
NSERC
Application summary
Our product is geared towards the prevention of dental cavities or caries in children and adults globally. Dental caries is the world's leading chronic childhood disease with a significant impact on patients, their families and health care system worldwide. Because of global population growth and increased tooth retention, the number of affected individuals is expected to grow substantially. We propose to use a "friendly" or probiotic bacterial strain to prevent dental caries. We identified one such bacterial strain, LAB813, from the mouth of a healthy cavity-free child and showed that it has potent anti-inhibitory activities against caries-causing bacteria. To guide us in the commercial development of the probiotic, a market assessment is now planned by a team comprising scientists, institutional (University of Toronto) Innovations and Partnerships Office, IPO, and a marketing assessment company (Adventus Research & Consulting, Inc.). Individuals tasked with performing the market assessment study are well-skilled and the relevant expertise and experience to conduct an assessment of the market in the specific markets of oral care, dental appliances and probiotics. Information such as market size, trends, opportunities/challenges/barriers to entry, adoption/commercialization of the technology, and product positioning will be gathered. Secondary market data will be reviewed prior to conducting a primary market research which will be in the form of in-depth interviews of a total of 20-22 key stakeholders. These stakeholders will comprise potential end-users/recommenders such as oral healthcare providers and companies interested in oral healthcare products, industry observers, regulatory agencies and venture capital firms. Interviews will be conducted posing questions related to satisfaction and solution, possible delivery modes, market acceptance, cost comparison, etc. Information gathered from all assessment will be compiled in a report that will be discussed and analyzed by the scientists and IPO. The market assessment report will be a crucial piece of the decision-making process in the development of the probiotic product for commercialization.